These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 12164870

  • 1. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
    Remuzzi A, Gagliardini E, Donadoni C, Fassi A, Sangalli F, Lepre MS, Remuzzi G, Benigni A.
    Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G.
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F.
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [Abstract] [Full Text] [Related]

  • 6. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
    Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G.
    Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341
    [Abstract] [Full Text] [Related]

  • 7. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G.
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [Abstract] [Full Text] [Related]

  • 8. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 9. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis.
    Mahmood J, Khan F, Okada S, Kumagai N, Morioka T, Oite T.
    Kidney Int; 2006 Nov; 70(9):1591-8. PubMed ID: 16985512
    [Abstract] [Full Text] [Related]

  • 10. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
    Bos H, Henning RH, De Boer E, Tiebosch AT, De Jong PE, De Zeeuw D, Navis G.
    Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387
    [Abstract] [Full Text] [Related]

  • 11. Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism.
    Remuzzi A, Fassi A, Sangalli F, Malanchini B, Mohamed EI, Bertani T, Remuzzi G.
    Exp Nephrol; 1998 Feb; 6(1):28-38. PubMed ID: 9523171
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G.
    Exp Nephrol; 1996 Feb; 4(1):19-25. PubMed ID: 8788596
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
    Zoja C, Liu XH, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A.
    Exp Nephrol; 1998 Feb; 6(2):121-31. PubMed ID: 9567218
    [Abstract] [Full Text] [Related]

  • 14. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [Abstract] [Full Text] [Related]

  • 15. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C, Benigni A, Camozzi D, Corna D, Longaretti L, Todeschini M, Remuzzi G.
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [Abstract] [Full Text] [Related]

  • 16. Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
    Plum J, Bünten B, Németh R, Grabensee B.
    J Am Soc Nephrol; 1998 Dec; 9(12):2223-34. PubMed ID: 9848776
    [Abstract] [Full Text] [Related]

  • 17. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.
    Macconi D, Sangalli F, Bonomelli M, Conti S, Condorelli L, Gagliardini E, Remuzzi G, Remuzzi A.
    Am J Pathol; 2009 Mar; 174(3):797-807. PubMed ID: 19164508
    [Abstract] [Full Text] [Related]

  • 18. Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats.
    Waanders F, Greven WL, Baynes JW, Thorpe SR, Kramer AB, Nagai R, Sakata N, van Goor H, Navis G.
    Nephrol Dial Transplant; 2005 Oct; 20(10):2060-70. PubMed ID: 15956058
    [Abstract] [Full Text] [Related]

  • 19. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ.
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [Abstract] [Full Text] [Related]

  • 20. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.
    Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, Gagliardini E, Rottoli D, Zanchi C, Abbate M, Ledbetter S, Remuzzi G.
    J Am Soc Nephrol; 2003 Jul; 14(7):1816-24. PubMed ID: 12819241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.